GREmLN leverages a graph-based architecture to represent gene-gene interactions to predict cell behavior for therapeutic ...

Merck & Co. has agreed to acquire Verona Pharma for $10 billion, the companies said, in a deal designed to expand the pharma ...

Methylation changes in microbiome-derived cfRNA enable more accurate CRC diagnosis than traditional DNA or abundance-based ...

Revolution Medicines' proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand ...

Pharmaceutical manufacturers are under immense pressure to streamline their processes, reduce waste, and improve output.

The potential of gene therapies will only be realized if the manufacturing challenges can be resolved, and that’s a tricky ...

Researchers predict that industry adoption of continuous manufacturing will accelerate in response to competitive pressure.

The best way to ensure consistency as bioassays are transferred among labs and scaled up is to plan early on for those ...

Results reveal that weight loss has significant effects on cellular processes that are known to affect metabolic health and ...

Findings suggest that Alzheimer’s risk genes drive tau buildup and spread through both network-based and independent mechanisms.

Mouse livers were engineered via a one-time genome editing to secrete a GLP-1, cutting weight gain and improving glucose ...

Total aggregate value of the drugs generating the highest sales in 2024 rose 6.5% vs. 2023, and jumped 53% over five years.